替曲膦与甲氧基异丁基异腈通过缩短注射至显像时间实现的效率:文献系统综述
本系统综述汇总已发表证据,比较锝-99m标记的甲氧基异丁基异腈(sestamibi)与替曲膦(tetrofosmin)在不同注射至显像时间下的检查效率与图像质量。复合数据显示替曲膦早期显像在主观图像质量或心/心外比值定量上与甲氧基异丁基异腈延迟显像等效,且替曲膦注射至采集时间显著更短、因肝脏活性导致的重复扫描率显著更低。
要点
- 替曲膦早期显像在主观图像质量或心/心外比值上与甲氧基异丁基异腈延迟显像等效。
- 替曲膦较甲氧基异丁基异腈平均提前15分钟显像,较替曲膦标准时间提前30分钟。
- 替曲膦注射至采集时间显著更短、患者等待更少;甲氧基异丁基异腈因肝脏活性重复扫描率显著更高。
核心结论
- 替曲膦早期显像在主观图像质量或心/心外比值定量上与甲氧基异丁基异腈延迟显像等效。
- 替曲膦注射至采集时间较甲氧基异丁基异腈显著更短,患者等待时间更少,检查效率更好。
- 甲氧基异丁基异腈因肝脏活性导致的重复扫描率较替曲膦显著更高,替曲膦吞吐量更好。
研究设计与样本
- 采用系统文献综述方法,识别并汇总比较甲氧基异丁基异腈与替曲膦在不同注射至显像时间下检查效率与图像质量的已发表证据。
主要发现
- 替曲膦早期显像与甲氧基异丁基异腈延迟显像在主观图像质量或心/心外比值定量上等效。
- 替曲膦早期与延迟显像的图像质量及心/心外比值相当或等效。
- 替曲膦较甲氧基异丁基异腈平均提前15分钟显像,较替曲膦标准时间提前30分钟显像。
- 替曲膦注射至采集时间较甲氧基异丁基异腈显著更短,患者等待时间更少。
- 甲氧基异丁基异腈因肝脏活性导致的重复扫描率较替曲膦显著更高。
局限性
- 原文指出,检验注射至显像最佳时间的已发表同行评议研究有限,难以识别基于证据的显像方案优化机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Based on superior image quality, more accurate gated images, and lower radiation exposure to patients, Technetium-99m (Tc-99m) based tracers are preferred over Thallium-201 for SPECT myocardial perfusion imaging. The two Tc-99m tracers, sestamibi and tetrofosmin, have many similar characteristics but there are differences in blood and liver clearance rates, as well as the recommended time after injection for imaging to achieve optimal image quality. Because published peer-reviewed studies examining optimal times between injection and imaging are limited, it can be difficult to identify evidence-based opportunities to optimize imaging protocols. Using systematic literature review methods, this study was designed to identify and consolidate the available evidence on the use of sestamibi compared to tetrofosmin for variable injection to imaging times in regard to test efficiency, including test length and re-scan rates, and image quality, including overall quality and cardiac to extra-cardiac ratios. The composite of this data shows that earlier imaging with tetrofosmin is equivalent to later imaging with sestamibi when assessing subjective image quality or when quantifying heart-to-extra-cardiac ratios. Image quality and heart-to-extra-cardiac ratios comparing early versus later imaging with tetrofosmin were comparable if not equivalent to each other. The equivalency of the imaging quality occurs with 15 minutes (on average) earlier imaging compared to sestamibi and 30 minutes compared to standard time tetrofosmin. The subjective findings of equivalent image quality are also shown with objective measurements of heart-to-extra-cardiac ratios. In this review, the significantly shorter injection-to-acquisition times with tetrofosmin compared to sestamibi resulted in better efficiency and less waiting times for patients; in addition, significantly higher re-scan rates with sestamibi compared to tetrofosmin due to hepatic activity contributed to better throughput with tetrofosmin.
引用
- Duvall WL, Case J, Lundbye J, et al. Efficiency of tetrofosmin versus sestamibi achieved through shorter injection-to-imaging times: A systematic review of the literature. J Nucl Cardiol. 2020. PMID: 32236839. doi:10.1007/s12350-020-02093-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。